The stock of Thermo Fisher Scientific Inc (NYSE: TMO) has increased by 0.27 when compared to last closing price of 573.06. Despite this, the company has experienced a 3.16% gain in its stock price over the last five trading sessions. seekingalpha.com reported 2025-01-22 that Thermo Fisher Scientific is poised for growth in 2025, driven by aging demographics, higher healthcare spending, and demand for innovative biological medicines. TMO’s diverse revenue streams, including life sciences, analytical instruments, specialty diagnostics, and biopharma services, ensure stability and resilience against market cycles. Thermo Fisher is a good bet for a well diversified portfolio.
Is It Worth Investing in Thermo Fisher Scientific Inc (NYSE: TMO) Right Now?
The price-to-earnings ratio for Thermo Fisher Scientific Inc (NYSE: TMO) is above average at 36.03x, Company’s 36-month beta value is 0.77.Analysts have differing opinions on the stock, with 18 analysts rating it as a “buy,” 8 as “overweight,” 7 as “hold,” and 0 as “sell.”
The public float for TMO is 381.97M, and currently, short sellers hold a 0.92% ratio of that floaft. The average trading volume of TMO on January 23, 2025 was 1.93M shares.
TMO’s Market Performance
TMO stock saw an increase of 3.16% in the past week, with a monthly gain of 11.32% and a quarterly increase of -4.51%. The volatility ratio for the week is 2.33%, and the volatility levels for the last 30 days are 2.09% for Thermo Fisher Scientific Inc (TMO). The simple moving average for the last 20 days is 6.13% for TMO stock, with a simple moving average of 0.78% for the last 200 days.
Analysts’ Opinion of TMO
Many brokerage firms have already submitted their reports for TMO stocks, with Bernstein repeating the rating for TMO by listing it as a “Outperform.” The predicted price for TMO in the upcoming period, according to Bernstein is $630 based on the research report published on January 10, 2025 of the current year 2025.
TMO Trading at 7.85% from the 50-Day Moving Average
After a stumble in the market that brought TMO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -8.49% of loss for the given period.
Volatility was left at 2.09%, however, over the last 30 days, the volatility rate increased by 2.33%, as shares surge +11.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.66% upper at present.
During the last 5 trading sessions, TMO rose by +3.16%, which changed the moving average for the period of 200-days by +0.70% in comparison to the 20-day moving average, which settled at $541.41. In addition, Thermo Fisher Scientific Inc saw 10.45% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TMO starting from CASPER MARC N, who sale 10,000 shares at the price of $532.20 back on Dec 03 ’24. After this action, CASPER MARC N now owns 101,192 shares of Thermo Fisher Scientific Inc, valued at $5,321,955 using the latest closing price.
CASPER MARC N, the Chairman & CEO of Thermo Fisher Scientific Inc, sale 10,000 shares at $530.26 during a trade that took place back on Dec 02 ’24, which means that CASPER MARC N is holding 111,192 shares at $5,302,604 based on the most recent closing price.
Stock Fundamentals for TMO
Current profitability levels for the company are sitting at:
- 0.17 for the present operating margin
- 0.41 for the gross margin
The net margin for Thermo Fisher Scientific Inc stands at 0.14. The total capital return value is set at 0.08. Equity return is now at value 13.01, with 6.22 for asset returns.
Based on Thermo Fisher Scientific Inc (TMO), the company’s capital structure generated 0.42 points at debt to capital in total, while cash flow to debt ratio is standing at 0.26. The debt to equity ratio resting at 0.72. The interest coverage ratio of the stock is 4.9.
Currently, EBITDA for the company is 11.08 billion with net debt to EBITDA at 2.71. When we switch over and look at the enterprise to sales, we see a ratio of 5.91. The receivables turnover for the company is 4.33for trailing twelve months and the total asset turnover is 0.42. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.63.
Conclusion
In a nutshell, Thermo Fisher Scientific Inc (TMO) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
